Evidence map›Paper›PMID 22761665›Full record

ArticlePloS one2012

A novel, non-apoptotic role for Scythe/BAT3: a functional switch between the pro- and anti-proliferative roles of p21 during the cell cycle.

Sheila T Yong, Xiao-Fan Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Article
  9. Bag6/Bat3/Scythe: a novel chaperone activity with diverse regulatory functions in protein biogenesis and degradation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sheila T YongDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United States of America.
Xiao-Fan Wang
Duke Medical Center · US

Funding

The role of TGF-beta in tumorigenesisR01CA151541 · NCI · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2010 to 2014
$1.5M
Rad17 - & p53-mediated apoptosis pathways in response to DNA damageR01CA123250 · NCI · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2006 to 2010
$1.4M
Mechanisms of TGF-B/Smad SignalingR01GM083000 · NIGMS · DUKE UNIVERSITY · PI WANG, XIAO-FAN · 2008 to 2011
$1.2M
NCI NIH HHS CA123250NCI NIH HHS R01 CA123250NCI NIH HHS R01 CA151541NIGMS NIH HHS GM83000NIGMS NIH HHS R01 GM083000
6 · The paper itself

Abstract

backgroundScythe/BAT3 is a member of the BAG protein family whose role in apoptosis has been extensively studied. However, since the developmental defects observed in Bat3-null mouse embryos cannot be explained solely by defects in apoptosis, we investigated whether BAT3 is also involved in cell-cycle progression. METHODS/PRINCIPAL

findingsUsing a stable-inducible Bat3-knockdown cellular system, we demonstrated that reduced BAT3 protein level causes a delay in both G1/S transition and G2/M progression. Concurrent with these changes in cell-cycle progression, we observed a reduction in the turnover and phosphorylation of the CDK inhibitor p21, which is best known as an inhibitor of DNA replication; however, phosphorylated p21 has also been shown to promote G2/M progression. Our findings indicate that in Bat3-knockdown cells, p21 continues to be synthesized during cell-cycle phases that do not normally require p21, resulting in p21 protein accumulation and a subsequent delay in cell-cycle progression. Finally, we showed that BAT3 co-localizes with p21 during the cell cycle and is required for the translocation of p21 from the cytoplasm to the nucleus during the G1/S transition and G2/M progression.

conclusionOur study reveals a novel, non-apoptotic role for BAT3 in cell-cycle regulation. By maintaining a low p21 protein level during the G1/S transition, BAT3 counteracts the inhibitory effect of p21 on DNA replication and thus enables the cells to progress from G1 to S phase. Conversely, during G2/M progression, BAT3 facilitates p21 phosphorylation by cyclin A/Cdk2, an event required for G2/M progression. BAT3 modulates these pro- and anti-proliferative roles of p21 at least in part by regulating cyclin A abundance, as well as p21 translocation between the cytoplasm and the nucleus to ensure that it functions in the appropriate intracellular compartment during each phase of the cell cycle.

Indexed as

ApoptosisCell ProliferationBlotting, WesternBone NeoplasmsCell CycleCyclin-Dependent Kinase Inhibitor p21DNA ReplicationFlow CytometryFluorescent Antibody TechniqueHumansMolecular ChaperonesOsteosarcomaPhosphorylationRNA, Small InterferingTumor Cells, CulturedBAG6 protein, humanCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Molecular ChaperonesRNA, Small Interfering

Identifiers

PMID22761665
PMCPMC3384656
OpenAlexW2148333786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.